Former Medical Director at GRAIL
Shilpen is a radiation oncologist by training and the Former Medical Director at GRAIL. Shilpen was responsible for running the clinical trials for Grail including the CCGA trial that led to breakthroughs and the upcoming Galleri cancer detection test. Shilpen was deeply involved in testing the different assays and analysing the results from each trial across over 50 cancers. He is now the Medical Director at Genentech where he runs the breast cancer and immuno-oncology division.